Introduction Growing evidence implicates brain- and body-wide energetic dysregulations as a hallmark of psychotic disorders [[1]]. Compared to the general population, and associated with altered bioenergetics, individuals with psychotic disorders experience elevated morbidity and mortality related to cardiovascular disease, dysglycemia, and cardiometabolic risk factors [[1-5]]. Cardiometabolic risk factors such as obesity, insulin resistance, and dyslipidemia are present early in illness [[3, 6]].
